Convergent Therapeutics, Inc.

Overview

Convergent Therapeutics, Inc. is a biotechnology company based in Cambridge, Massachusetts, founded in 2021. The company focuses on developing next-generation targeted radiotherapies, particularly alpha radioantibodies, aimed at treating prostate cancer and other cancers. Their proprietary dual-targeted radionuclide therapies utilize monoclonal antibodies conjugated with alpha-emitting isotopes, such as actinium-225, to effectively target cancer cells while minimizing harm to healthy tissues.

The lead product candidate, CONV01-α, targets prostate-specific membrane antigen (PSMA) and is designed for PSMA-positive castration-resistant prostate cancer. It has shown promising results in Phase 1/2 trials and has received FDA clearance for its IND application, with Phase 2 trials set to begin in 2024. Another candidate, In-111 rosopatamab tetraxetan, is also in Phase 2 development for the same indication. The company employs innovative radioantibody technology to enhance the precision of radiation therapy, focusing on improving treatment outcomes for cancer patients.

Basic Information

Contact Details

• Phone: +1 617-710-4289
• Website: convergentrx.com
• LinkedIn: linkedin.com/company/convergent-therapeutics

Key Focus Areas & Initiatives

• Biotechnology research
• Pharmaceuticals
• Short-range radiation
• Radiopharmaceutical development
• Research and development in the physical, engineering, and life sciences
• Actinium-225
• Radiopharmaceuticals
• Targeted alpha therapy
• Radioisotope conjugates
• Radioligand therapy
• Healthcare
• Cancer biomarkers
• DNA damage induction
• Alpha emitters
• PSMA-targeted therapy
• PSMA antibodies
• PSMA targeting
• Monoclonal antibodies
• Alpha-emitting payloads
• Metastatic castration-resistant prostate cancer
• Alpha radiation
• Next-generation radiotherapy
• Targeted radiotherapies
• Clinical development
• Alpha particle therapy
• CONV01-α
• Cancer targeting
• Radioantibodies
• Prostate cancer
• Radioantibody platform
• Precision radiotherapy
• Targeted cancer therapy
• Precision oncology
• Radiotherapy
• Oncology therapeutics
• Cancer treatment
• Clinical trials
• Cancer cell targeting
• Metastatic cancer
• Biotech innovation
• Clinical trial updates
• Medical
• Health care
• Health, wellness & fitness
• Hospital & health care

Technologies Used

• Google Tag Manager
• IoT
• Mobile Friendly
• Outlook
• Remote
• Typekit
• WordPress.org